Education
About Us
Working with TipRanks
Follow Us
Kindly MD (NAKA)
NASDAQ:NAKA
NAKA Stock Chart & Stats
$0.46
--
Market closed
$0.46
--
Day’s Range― - ―
52-Week Range$0.34 - $34.77
Previous CloseN/A
VolumeN/A
Average Volume (3M)30.98M
Market Cap
N/A
Enterprise Value$3.04M
Total Cash (Recent Filing)$24.19M
Total Debt (Recent Filing)$203.54M
Price to Earnings (P/E)―
Beta4.56
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding439,850,900
10 Day Avg. Volume32,220,503
30 Day Avg. Volume30,978,537
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)2.60
Price to Sales (P/S)2.46
P/FCF Ratio-2.17
Enterprise Value/Market Cap10.00T>
Enterprise Value/Revenue1.53
Enterprise Value/Gross Profit1.55
Enterprise Value/Ebitda-0.03
Forecast
1Y Price Target
$1.25Price Target Upside171.74% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Acquisition Expands Media ReachAnalyst expects the pending acquisition of BTC Inc. to add meaningful scale and provide an established digital-asset media platform that can broaden audience reach and monetization opportunities.
Bitcoin Treasury StrategyAnalyst notes the company's Bitcoin treasury strategy and plans to meaningfully increase holdings, which could strengthen the balance sheet and attract investors seeking direct crypto exposure.
Valuation Support From Sum-of-the-partsAnalyst's sum-of-the-parts valuation, which factors in revenue multiples and the expected future value of accumulated Bitcoin, supports a materially higher price target and implies potential upside.
Bears Say
Digital-asset Market Pullback And Revenue DowngradesAnalyst highlights a pullback in digital-asset prices and sentiment that led to lowered revenue estimates for 2026, increasing the risk of weaker-than-expected top-line performance.
Funding Needs For Growth And M&AAnalyst warns that additional Bitcoin purchases or further M&A could require new capital, creating dilution risk or financing pressure if external funding is necessary.
One-time Transaction Costs And Revised OutlookAnalyst points to a higher adjusted EBITDA loss tied to transient go-public expenses and a lowered price target that reflects reduced near-term financial estimates.
Kindly MD News
NAKA FAQ
What was Kindly MD’s price range in the past 12 months?
Kindly MD lowest stock price was $0.34 and its highest was $34.77 in the past 12 months.
What is Kindly MD’s market cap?
Currently, no data Available
When is Kindly MD’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Kindly MD’s earnings last quarter?
Currently, no data Available
Is Kindly MD overvalued?
According to Wall Street analysts Kindly MD’s price is currently Undervalued.
Does Kindly MD pay dividends?
Kindly MD does not currently pay dividends.
What is Kindly MD’s EPS estimate?
Kindly MD’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Kindly MD have?
Kindly MD has 439,850,900 shares outstanding.
What happened to Kindly MD’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Kindly MD?
Currently, no hedge funds are holding shares in NAKA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Kindly MD
Kindly MD, Inc., a healthcare and healthcare data company, provides direct health care services to patients integrating prescription medicine and behavioral health services. The company offers specialty outpatient clinical services based on a subscription and fee-for-service basis to augment traditional healthcare. It provides evaluation and management services, including chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support, overdose education, peer support, limited urgent care, preventative medicine, travel, and hormone therapy; and data collection and research, and online and email campaign marketing services, as well as engages in the retail sale of health care products through clinics and online. Kindly MD, Inc. was formerly known as Utah Therapeutic Health Center, LLC and changed its name to Kindly MD, Inc. in March 2022. The company was incorporated in 2019 and is based in Salt Lake City, Utah.
NAKA Stock 12 Month Forecast
Average Price Target
$1.25
▲(171.74% Upside)
Technical Analysis
EyePoint Pharmaceuticals
―
Inhibrx Biosciences Inc
―
Rapport Therapeutics, Inc.
―
Sila Realty Trust, Inc.
―
Beta Bionics, Inc.
―
Ownership Overview
6.81% Insiders
1.84% Mutual Funds
12.13% Other Institutional Investors
75.49% Public Companies and
Individual Investors